Sustained expression of proteoglycans and collagen type III/type I ratio in a calcified tendinopathy model

Rheumatology

Volumn 49, Issue 2, 2010, Pages 231-239

  Lui, Pauline Po Yee ^a   Chan, Lai Shan ^a   Lee, Yuk Wa ^a   Fu, Sai Chuen ^a   Chan, Kai Ming ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Collagens; Extracellular matrix; Proteoglycans; Tendinopathy

Indexed keywords

AGGRECAN; BIGLYCAN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; DECORIN; FIBROMODULIN; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIFICATION; CARTILAGE CELL; CELLULAR DISTRIBUTION; CHONDROGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION; MALE; NONHUMAN; PATELLA TENDON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TENDON RUPTURE;

EID: 77950422608     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep384     Document Type: Article

References (54)

1. Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clin Sports Med 2003;22: 675-92.
2. Jim YF, Hsu HC, Chang CY, Wu JJ, Chang T. Coexistence of calcific tendinitis and rotator cuff tear: an arthrographic study. Skeletal Radiol 1993;22:183-5.
3. Hashimoto T, Nobuhara K, Hamada T. Pathologic evidence of degeneration as a primary cause of rotator cuff tear. Clin Orthop Relat Res 2003;415:111-20.
4. Aina R, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology 2001;221: 455-61.
5. Fenwick S, Harrall R, Hackney R, Bord D, Horner A, Hazleman B, Riley G. Endochondral ossification in Achilles and patella tendinopathy. Rheumatology 2002;41:474-6.
6. Lagier R, Gerster JC. Disabling ossification of the patellar tendon. Ann Rheum Dis 1991;50:338-9.
7. Matsumoto I, Ito Y, Tomo H, Nakao Y, Takaoka K. Case reports: ossified mass of the rotator cuff tendon in the subacromial bursa. Clin Orthop Relat Res 2005;437: 247-50.
8. Faure G, Daculsi G. Calcified tendonitis: a review. Ann Rheum Dis 1983;42:49-53.
9. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 1994;53:359-66.
10. Bank RA, Tekoppele JM, Oostingh G, Hazleman BL, Riley GP. Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1999;58:35-41.
11. de Mos M, van El B, DeGroot J et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med 2007;35:1549-56.
12. Maffulli N, Barrass V, Ewen SW. Light microscopic histology of Achilles tendon ruptures. A comparison with unruptured tendons. Am J Sports Med 2000;28: 857-63.
13. Riley GP. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2003;42:1-14.
14. Astrom M, Rausing A. Chronic Achilles tendinopathy. A survey of surgical and histopathologic findings. Clin Orthop 1995;316:151-64.
15. Movin T, Gad A, Reinholf FP, Rolf C. Tendon pathology in long-standing achillodynia. Acta Orthop Scand 1997;68: 170-5.
16. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994;53: 367-76.
17. Birch HL, Bailey AJ, Goodship AE. Macroscopic 'degeneration' of equine superficial digital flexor tendon is accompanied by a change in extracellular matrix composition. Equine Vet J 1998;30:534-9.
18. Maffulli N, Waterston SW, Ewen SW. Ruptured Achilles tendons show increased lectin stainability. Med Sci Sports Exerc 2002;34:1057-64.
19. Riley GP, Harrall RL, Cawston TE, Hazleman BL, Mackie EJ. Tenascin-C and human tendon degeneration. Am J Pathol 1996;149:933-43.
20. Lehto M, Jozsa L, Kvist M, Jarvinen M, Balint BJ, Reffy A. Fibronectin in the ruptured human Achilles tendon and its paratendon. An immunoperoxidase study. Ann Chir Gynaecol 1990;79:72-7.
21. Tillander B, Franzen L, Norlin R. Fibronectin, MMP-1 and histologic changes in rotator cuff disease. J Orthop Res 2002;20:1358-64.
22. Corps AN, Robinson AH, Movin T et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology 2004; 43:969-72.
23. Xu YH, Murrell GAC. The basic science of tendinopathy. Clin Orthop Relat Res 2008;466:1528-38.
24. Murata H, Tanaka H, Taguchi T et al. Dexamethasone induces human spinal ligament derived cells toward osteogenic differentiation. J Cell Biochem 2004;92: 715-22.
25. de Mos M, Koevoet W, ven Schie HTM et al. In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med 2009;37:1214-22.
26. Lui PPY, Fu SC, Chan LS, Hung LK, Chan KM. Chondrocyte phenotype and ectopic ossification in collagenase-induced tendon degeneration. J Histochem Cytochem 2009;57:91-100.
27. Lui PPY, Cheuk YC, Hung LK, Fu SC, Chan KM. Increased apoptosis at the late stage of tendon healing. Wound Repair Regen 2007;15:702-7.
28. Fu SC, Wong YP, Chan BP et al. The roles of bone morphogenetic protein (BMP) 12 in stimulating the proliferation and matrix production of human patellar tendon fibroblasts. Life Sci 2003;72:2965-74.
29. Ireland D, Harrall R, Curry V, Holloway G, Hackney R, Hazleman B et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001; 20:159-69.
30. Lapiere CM, Nusgens B, Pierard GE. Interaction between collagen type I and type III in conditioning bundles organization. Connect Tissue Res 1977;5:21-9.
31. Corps AN, Robinson AHN, Movin T, Costa ML, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology 2006;45:291-4.
32. Fu SC, Chan KM, Rolf CG. Increased deposition of sulfated glycosaminoglycans in human patellar tendinopathy. Clin J Sport Med 2007;17:129-34.
33. Tallon C, Maffulli N, Ewen SW. Ruptured Achilles tendons are significantly more degenerated than tendinopathic tendons. Med Sci Sports Exerc 2001;33:1983-90.
34. Corps AN, Robinson AHN, Movin T, Costa ML, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology 2006;45:291-4.
35. Nakamura N, Hart DA, Boorman RS et al. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J Orthop Res 2000;18:517-23.
36. Smith MM, Sakurai G, Smith SM et al. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis Rheum 2008;58: 1055-66.
37. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fibrils in tendons of biglycan/ fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 2002;16: 673-80.
38. Xu T, Bianco P, Fisher L et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 1998;20:78-82.
39. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M. Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun 2003;305:6-9.
40. Maffulli N, Reaper J, Ewen SW, Waterston SE, Barrass V. Chondral metaplasia in calcific insertional tendinopathy of the Achilles tendon. Clin J Sport Med 2006;16:329-34.
41. de Mos M, Koevoet W, ven Schie HTM et al. In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med 2009;37:1214-22.
42. Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am 2005;87: 187-202.
43. Yokota A, Gimbel JA, Williams GR, Sslowsky LJ. Supraspinatus tendon composition remains altered long after tendon detachment. J Shoulder Elbow Surg 2005; 14(1 Suppl. S),S72-8.
44. Archer RS, Bayley JIL, Archer CW, Ali SY. Cell and matrix changes associated with pathological calcification of the human rotator cuff tendons. J Anat 1993;182:1-12.
45. Uhthoff HK, Sarkar K, Maynard JA. Calcifying tendonitisa new concept of its pathogenesis. Clin Orthop Relat Res 1976;118:164-8.
46. Chard MD, Cawston TE, Riley GP, Gresham GA, Hazleman BL. Rotator cuff degeneration and lateral epicondylitis - a comparative histological study. Ann Rheum Dis 1994;53:30-4.
47. Archambault JM, Jelinsky SA, Lake SP, Hill AA, Glaser DL, Soslowsky LJ. Rat supraspinatus tendon expresses cartilage markers with overuse. J Orthop Res 2007;25: 617-24.
48. Clegg PD, Strassburg S, Smith RK. Cell phenotypic variation in normal and damaged tendons. Int J Exp Pathol 2007;88:227-35.
49. Riley GP. Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports 2005;15:241-51.
50. Hildebrand A, Romaris M, Rasmussen LM et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994;302:527-34.
51. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 1995;83:357-60.
52. Fu SC, Wong YP, Cheuk YC, Lee KM, Chan KM. TGF-β1 reverses the effects of matrix anchorage on the gene expression of decorin and procollagen type I in tendon fibroblasts. Clin Orthop Relat Res 2005; 431:226-32.
53. Young MF, Bi Y, Ameye L, Chen XD. Biglycan knockout mice: new models for musculoskeletal diseases. Glycocon J 2003;19:257-62.
54. Barry F, Boynton RF, Liu B, Murphy JM. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exptl Cell Res 2001;268: 189-200.